Pfizer CEO Profits After COVID Vaccine Announcement

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

data-driven tools
Leverage Data-Driven Tools and Local SEO for Maximum Search Engine Rankings
July 26, 2024

As businesses continue to navigate the digital landscape, data-driven tools are more crucial than ever for effective SEO strategies. Understanding and implementing the proper SEO practices can make a significant difference with evolving algorithms and competitive markets. Given that 75% of users never scroll past the first page of search results, this statistic underscores…

Read More
On-device AI
On-Device AI is Today’s Tech Innovation, Competition and Market Leadership Driver
July 26, 2024

On-device AI revolutionizes the tech landscape, making it a critical factor for industry dominance. This cutting-edge technology directly integrates advanced AI capabilities into devices, transforming consumer and enterprise applications. This shift stems from the need for improved performance, reduced latency, enhanced data privacy & security, and personalized user experiences. With advancements in neural processing…

Read More
modern supply chains
The Role of AI in Modern Supply Chains: Insights from Aaron Hatfield at Arvist
July 26, 2024

Artificial intelligence rapidly transforms modern supply chains, with companies like Arvist leading the charge. In a recent episode of Hammer Down, hosted by Mike Bush, Aaron Hatfield, the Head of Sales at Arvist, sheds light on AI’s practical applications and benefits in enhancing supply chain operations. Is AI in the supply chain a double-edged…

Read More
semiconductor manufacturing
Training New Semiconductor Manufacturing Professionals is Key to Meet Coming Domestic Manufacturing Demand
July 26, 2024

Over the past few years, the U.S. has made significant strides in semiconductor manufacturing, driven by substantial investments and strategic policies. With the CHIPS Act expected to triple domestic semiconductor manufacturing capacity by 2032, the need for a skilled workforce is more urgent than ever. This discussion explores the key question: What does the…

Read More